GTx, Inc (GTXI) Covered Calls

GTx, Inc covered calls GTx, Inc. is biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition.

You can sell covered calls on GTx, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GTXI (prices last updated Thu 4:16 PM ET):

GTx, Inc (GTXI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.14 -0.01 1.13 1.15 118K -0.5 0.0B
Covered Calls For GTx, Inc (GTXI)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 2.5 0.00 1.15 0.0% 0.0%
Aug 16 2.5 0.20 0.95 21.1% 63.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

GTx, Inc. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for prostate and breast cancer, cancer supportive care, including prevention and treatment of cancer-related muscle wasting or cachexia, and other serious medical conditions. The company also develops selective androgen receptor modulators, a new class of drugs with the potential to prevent and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia, as well as the potential to be used as a hormonal therapy for the treatment of metastatic breast cancer. Its SARM product candidate, enobosarm (GTx-024), has to date been evaluated in fourteen completed or ongoing clinical trials enrolling approximately 1,320 subjects, including in three Phase 2 and two Phase 3 clinical trials. GTx was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.